Literature DB >> 32402850

Rational targeting of Wzb phosphatase and Wzc kinase interaction inhibits extracellular polysaccharides synthesis and biofilm formation in Acinetobacter baumannii.

Monalisa Tiwari1, Shruti Panwar1, Akansha Kothidar1, Vishvanath Tiwari2.   

Abstract

Acinetobacter baumannii is an opportunistic nosocomial pathogen, and responsible for high mortality and morbidity. Biofilm formation is one of the resistance determinants, where extracellular polysaccharide (EPS) is an essential component. EPS synthesis and its export is regulated by the bacterial Wza-Wzb-Wzc system. Wzc exhibits auto-phosphorylation protein tyrosine kinase activity, while Wzb is a protein tyrosine phosphatase. Wzb mediates dephosphorylation of Wzc. Dephosphorylated Wzc is required for the export of the EPS through porin Wza-Wzc complex. It shows that the interaction of Wzb with Wzc is critical for the export of EPS. Therefore, if the Wzb-Wzc interaction is inhibited, then it might hinder the EPS transport and diminish the biofilm formation. In this study, we have modelled the Wzb, and Wzc proteins and further validated using PSVS, ProSA, RAMPAGE, and PDBsum. The modelled proteins were used for protein-protein docking. The docked protein-protein complex was minimized by Schrodinger software using OPLS_2005 force field. The binding site of the minimized Wzb-Wzc complex was identified by Sitemap. The high throughput virtual screening identified Labetalol hydrochloride and 4-{1-hydroxy-2-[(1-methyl-3-phenylpropyl) amino] propyl} phenol from FDA-approved drug library based on their interaction at the interface of Wzb-Wzc complex. The inhibitor-protein complex was further undergone molecular mechanics analysis using Generalized Born model and Solvent Accessibility (MMGBSA) to estimate the binding free energies. The lead was also used to generate the pharmacophore model and screening the molecule with antimicrobial scaffold. The identified lead was experimentally validated for its effect on EPS quantity and biofilm formation by A. baumannii. Wzb-Wzc interaction is essential for biofilm and EPS export; hence, the identified lead might be useful to regulate the biofilm formation by A. baumannii.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acinetobacter baumannii; Antibiotics; Biofilm; Exopolysaccharides; Membrane proteins; Tyrosine kinase; Tyrosine phosphatase; Wzb protein; Wzb-wzc interaction; Wzc protein

Mesh:

Substances:

Year:  2020        PMID: 32402850     DOI: 10.1016/j.carres.2020.108025

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  6 in total

1.  Decoding Acinetobacter baumannii biofilm dynamics and associated protein markers: proteomic and bioinformatics approach.

Authors:  Monika Choudhary; Shubham Kaushik; Arti Kapil; Rahul Shrivastava; Jitendraa Vashistt
Journal:  Arch Microbiol       Date:  2022-03-03       Impact factor: 2.552

2.  Isolation and Characterization of Lytic Bacteriophages Targeting Diverse Enterobacter spp. Clinical Isolates.

Authors:  Amanda G Finney; Jalyne M Perry; Daniel R Evans; Kevin J Westbrook; Christi L McElheny; Alina Iovleva; Yohei Doi; Ryan K Shields; Daria Van Tyne
Journal:  Phage (New Rochelle)       Date:  2022-03-18

3.  Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus.

Authors:  Vishvanath Tiwari
Journal:  Int J Biol Macromol       Date:  2021-01-07       Impact factor: 6.953

4.  Novel hybrid antiviral VTRRT-13V2.1 against SARS-CoV2 main protease: retro-combinatorial synthesis and molecular dynamics analysis.

Authors:  Vishvanath Tiwari
Journal:  Heliyon       Date:  2020-09-30

Review 5.  Gram-Negative Bacteria Holding Together in a Biofilm: The Acinetobacter baumannii Way.

Authors:  Arianna Pompilio; Daniela Scribano; Meysam Sarshar; Giovanni Di Bonaventura; Anna Teresa Palamara; Cecilia Ambrosi
Journal:  Microorganisms       Date:  2021-06-22

6.  De novo design, retrosynthetic analysis and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2.

Authors:  Vishvanath Tiwari
Journal:  Biol Open       Date:  2020-10-15       Impact factor: 2.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.